251 related articles for article (PubMed ID: 10424246)
21. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
22. [Severe exacerbation of chronic hepatitis B during therapy with corticosteroids and lamivudine therapy and successful short-term combination therapy with interferon-beta and interferon-gamma].
Musch E; Malek M; Chrissafidou A
Z Gastroenterol; 2003 May; 41(5):425-8. PubMed ID: 12772056
[TBL] [Abstract][Full Text] [Related]
23. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
[TBL] [Abstract][Full Text] [Related]
24. [Prognosis and treatment of chronic viral hepatitis].
Klotz F; Debonne JM
Med Trop (Mars); 1991; 51(1):15-28. PubMed ID: 1712889
[TBL] [Abstract][Full Text] [Related]
25. [Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis].
Ettinger OA; Nikitin IG; Storozhakov GI
Ter Arkh; 1999; 71(12):69-72. PubMed ID: 10647210
[No Abstract] [Full Text] [Related]
26. [The neuropsychiatric side effects of the interferon therapy in patients with chronic hepatitis B and C].
Lapiński TW; Prokopowicz D
Pol Merkur Lekarski; 1999 Jul; 7(37):8-11. PubMed ID: 10522402
[TBL] [Abstract][Full Text] [Related]
27. Therapy of chronic viral hepatitis.
Goeser T; Theilmann L
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):571-6. PubMed ID: 7533038
[TBL] [Abstract][Full Text] [Related]
28. [Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?].
Vella FS; Orlando P; Attanasi F; Simone B; Mundo A; Lopalco P; Schiraldi O; Antonaci S
Recenti Prog Med; 2001 Feb; 92(2):107-12. PubMed ID: 11294098
[TBL] [Abstract][Full Text] [Related]
29. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gangemi JD; Tennant BC; Gerin JL
Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
[TBL] [Abstract][Full Text] [Related]
30. Syndromes and complications of interferon therapy.
Borg FA; Isenberg DA
Curr Opin Rheumatol; 2007 Jan; 19(1):61-6. PubMed ID: 17143098
[TBL] [Abstract][Full Text] [Related]
31. [Treatment and prevention of viral hepatitis].
Palmović D
Lijec Vjesn; 2004; 126(9-10):254-60. PubMed ID: 15918324
[TBL] [Abstract][Full Text] [Related]
32. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
[TBL] [Abstract][Full Text] [Related]
33. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
[TBL] [Abstract][Full Text] [Related]
34. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.
Wirth S; Lang T; Gehring S; Gerner P
Hepatology; 2002 Nov; 36(5):1280-4. PubMed ID: 12395341
[TBL] [Abstract][Full Text] [Related]
35. Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection.
Peoc'h K; Dubel L; Chazouillères O; Ocwieja T; Duron F; Poupon R; Johanet C
Am J Gastroenterol; 2001 Oct; 96(10):2978-83. PubMed ID: 11693336
[TBL] [Abstract][Full Text] [Related]
36. Interferon for chronic viral hepatitis.
Med Lett Drugs Ther; 1990 Jan; 32(809):1-2. PubMed ID: 2104647
[No Abstract] [Full Text] [Related]
37. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
[TBL] [Abstract][Full Text] [Related]
38. Update on viral hepatitis: 2005.
Wong SN; Lok AS
Curr Opin Gastroenterol; 2006 May; 22(3):241-7. PubMed ID: 16550038
[TBL] [Abstract][Full Text] [Related]
39. HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C.
Romero-Gómez M; González-Escribano MF; Torres B; Barroso N; Montes-Cano MA; Sánchez-Muñoz D; Núñez-Roldan A; Aguilar-Reina J
Am J Gastroenterol; 2003 Jul; 98(7):1621-6. PubMed ID: 12873589
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C.
Gatselis NK; Georgiadou SP; Koukoulis GK; Tassopoulos N; Zachou K; Liaskos C; Hatzakis A; Dalekos GN
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1563-73. PubMed ID: 17094775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
